GEODON may increase the risk of changes to your heart rhythm. You should not take GEODON if you have certain kinds of heart conditions that change your heart rhythm, a recent heart attack, heart failure, or take certain medicines known to change heart rhythm. GEODON may increase the risk of changes to your heart rhythm. You should not take GEODON if you have certain kinds of heart conditions that change your heart rhythm, a recent heart attack, heart failure, or take certain medicines known to change heart rhythm. Geodon is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. Learn about ziprasidone (Geodon), a drug prescribed for the treatment of psychoses such as schizophrenia and bipolar disorder. Information about dosage, side effects, and patient safety is included. Antipsychotic Drug Warnings: There have been 113 warnings from nine countries (Australia, Canada, Denmark, Ireland, Japan, New Zealand, South Africa, United Kingdom and United States) and the European Union warning that antipsychotics cause harmful side effects. Learn about the potential side effects of Abilify (aripiprazole). Includes common and rare side effects information for consumers and healthcare professionals. Learn about Geodon (Ziprasidone) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. Abilify has been studied thoroughly in clinical trials. In these studies, the side effects that occur in a group of people taking the drug are documented and are then compared to side effects that occur in another group of people not taking the medicine. Find patient medical information for Invega Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.